drugset / Trial / NCT07384663

EFFICACY OF IV VERSUS ORAL IRON IN THE TREATMENT OF IRON DEFICIENCY ANEMIA DURING PREGNANCY

NCT07384663

Phase 1 Completed 112 enrolled Dr Salaha Azam
RandomizedParallel-groupSingle-blindTreatment

Summary

This study was planned to compare outcomes of IV versus oral iron in the treatment of iron deficiency anemia during pregnancy. This study was used to investigate the efficacy of two new formulations of iron both in IV and oral form with fewer side effects. We compared the efficacy of Intravenous Ferric Carboxymaltose with Oral polysaccharide iron complex. The better mode of treatment will be administered in future to treat this condition, that will surely improve the fetal and maternal outcome.

Timeline

Start
2025-06-01
Primary completion
2025-11-30
Completion
2025-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ferric carboxymaltose Other / unclassified 10 mg/kg Intravenous
Comparator Ferric carboxymaltose Other / unclassified 500 mg Intravenous
Comparator Polysaccharide iron complex Unknown 150 mg Oral